Pancreatic islet transplantation: is purification necessary?

Area of Science:

• Transplantation immunology
• Endocrinology
• Surgical innovation

Background:

• Islet allotransplantation is a promising treatment for type 1 diabetes.
• Historically, low success rates have been attributed to poor islet preparation quality, specifically exocrine contamination.
• This has led to extensive efforts in islet purification to prevent graft rejection and improve engraftment.

Purpose of the Study:

• To re-evaluate the impact of exocrine contamination on islet allotransplantation outcomes.
• To challenge the assumption that highly purified islets are essential for successful transplantation.
• To propose an alternative strategy for improving clinical islet allotransplantation success.

Main Methods:

• Review of existing experimental data on exocrine contamination in islet preparations.
• Analysis of current clinical trial strategies for islet allotransplantation.
• Comparative assessment of purification versus immunosuppression protocols.

Main Results:

• Evidence suggests that over-purification of islets may not be beneficial and could potentially be detrimental.
• Exocrine contamination's negative impact on engraftment and immunogenicity appears to be overestimated in current practices.
• Less pure islet preparations might be advantageous when combined with optimized immunosuppressive protocols.

Conclusions:

• Current clinical trials may be overly focused on achieving high levels of islet purity.
• Maximizing islet yield using less pure preparations, alongside novel immunosuppressive strategies, is a viable approach.
• This strategy could enhance engraftment and improve outcomes until advanced therapies like antigen-specific tolerance or biohybrid artificial pancreas become available.